HEADER TRANSFERASE/TRANSFERASE INHIBITOR 08-JUL-15 5CF4 TITLE CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH N,N-DICYCLOPROPYL- TITLE 2 10-ETHYL-7-[(3-METHOXYPROPYL)AMINO] -3-METHYL-3,5,8,10- TITLE 3 TETRAAZATRICYCLO[7.3.0.0,6] DODECA-1(9),2(6),4,7,11-PENTAENE-11- TITLE 4 CARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, UNP RESIDUES 839-1132; COMPND 5 SYNONYM: JANUS KINASE 2,JAK-2; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.S.SACK REVDAT 4 06-NOV-24 5CF4 1 REMARK REVDAT 3 22-NOV-17 5CF4 1 REMARK REVDAT 2 02-SEP-15 5CF4 1 JRNL REVDAT 1 26-AUG-15 5CF4 0 JRNL AUTH A.C.HART,G.M.SCHROEDER,H.WAN,J.GREBINSKI,J.INGHRIM, JRNL AUTH 2 J.KEMPSON,J.GUO,W.J.PITTS,J.S.TOKARSKI,J.S.SACK,J.A.KHAN, JRNL AUTH 3 J.LIPPY,M.V.LORENZI,D.YOU,T.MCDEVITT,R.VUPPUGALLA,Y.ZHANG, JRNL AUTH 4 L.J.LOMBARDO,G.L.TRAINOR,A.V.PURANDARE JRNL TITL STRUCTURE-BASED DESIGN OF SELECTIVE JANUS KINASE 2 JRNL TITL 2 IMIDAZO[4,5-D]PYRROLO[2,3-B]PYRIDINE INHIBITORS. JRNL REF ACS MED.CHEM.LETT. V. 6 845 2015 JRNL REFN ISSN 1948-5875 JRNL PMID 26288682 JRNL DOI 10.1021/ACSMEDCHEMLETT.5B00225 REMARK 2 REMARK 2 RESOLUTION. 2.38 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.38 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.10 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 34956 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.252 REMARK 3 R VALUE (WORKING SET) : 0.252 REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.190 REMARK 3 FREE R VALUE TEST SET COUNT : 764 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 18 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.38 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.45 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.52 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2912 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.3003 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2855 REMARK 3 BIN R VALUE (WORKING SET) : 0.3000 REMARK 3 BIN FREE R VALUE : 0.3161 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 1.96 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 57 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4740 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 60 REMARK 3 SOLVENT ATOMS : 249 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 47.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.51 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.39190 REMARK 3 B22 (A**2) : -3.39190 REMARK 3 B33 (A**2) : 6.78390 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.376 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.354 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.227 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.352 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.229 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.897 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.895 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4911 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6633 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1778 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 133 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 733 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4911 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 594 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5632 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.11 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.11 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.32 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5CF4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-JUL-15. REMARK 100 THE DEPOSITION ID IS D_1000211527. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-MAY-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MICROMAX CONFOCAL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 92 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 (DENZO), HKL-2000 REMARK 200 (DENZO) REMARK 200 DATA SCALING SOFTWARE : HKL-2000 (SCALEPACK), HKL-2000 REMARK 200 (SCALEPACK) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35435 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.380 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.13700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.38 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.47 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.00 REMARK 200 R MERGE FOR SHELL (I) : 0.46200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.94 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM MES BUFFER, 100MM NACL, 28% REMARK 280 (W/V) PEG3350, 2MM DTT AND 200MM TRI-SODIUM CITRATE, PH 6.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 35.25000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 17.62500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 52.87500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 818 REMARK 465 GLY A 819 REMARK 465 SER A 820 REMARK 465 SER A 821 REMARK 465 HIS A 822 REMARK 465 HIS A 823 REMARK 465 HIS A 824 REMARK 465 HIS A 825 REMARK 465 HIS A 826 REMARK 465 HIS A 827 REMARK 465 SER A 828 REMARK 465 SER A 829 REMARK 465 GLY A 830 REMARK 465 LEU A 831 REMARK 465 VAL A 832 REMARK 465 PRO A 833 REMARK 465 ARG A 834 REMARK 465 GLY A 835 REMARK 465 SER A 836 REMARK 465 HIS A 837 REMARK 465 MET A 838 REMARK 465 ARG A 839 REMARK 465 ASP A 840 REMARK 465 PRO A 841 REMARK 465 THR A 842 REMARK 465 SER A 919 REMARK 465 ALA A 920 REMARK 465 GLY A 921 REMARK 465 ARG A 922 REMARK 465 GLY A 1132 REMARK 465 HIS A 1133 REMARK 465 HIS A 1134 REMARK 465 HIS A 1135 REMARK 465 HIS A 1136 REMARK 465 HIS A 1137 REMARK 465 HIS A 1138 REMARK 465 MET B 818 REMARK 465 GLY B 819 REMARK 465 SER B 820 REMARK 465 SER B 821 REMARK 465 HIS B 822 REMARK 465 HIS B 823 REMARK 465 HIS B 824 REMARK 465 HIS B 825 REMARK 465 HIS B 826 REMARK 465 HIS B 827 REMARK 465 SER B 828 REMARK 465 SER B 829 REMARK 465 GLY B 830 REMARK 465 LEU B 831 REMARK 465 VAL B 832 REMARK 465 PRO B 833 REMARK 465 ARG B 834 REMARK 465 GLY B 835 REMARK 465 SER B 836 REMARK 465 HIS B 837 REMARK 465 MET B 838 REMARK 465 ARG B 922 REMARK 465 HIS B 1133 REMARK 465 HIS B 1134 REMARK 465 HIS B 1135 REMARK 465 HIS B 1136 REMARK 465 HIS B 1137 REMARK 465 HIS B 1138 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 885 CG CD OE1 NE2 REMARK 470 GLN A1003 CG CD OE1 NE2 REMARK 470 GLU A1015 CG CD OE1 OE2 REMARK 470 LYS A1069 CG CD CE NZ REMARK 470 GLN A1070 CG CD OE1 NE2 REMARK 470 ARG B 839 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 923 CG CD NE CZ NH1 NH2 REMARK 470 GLU B1012 CB CG CD OE1 OE2 REMARK 470 GLU B1015 CG CD OE1 OE2 REMARK 470 LYS B1053 CG CD CE NZ REMARK 470 LYS B1069 CG CD CE NZ REMARK 470 GLN B1070 CG CD OE1 NE2 REMARK 470 GLN B1072 CG CD OE1 NE2 REMARK 470 MET B1073 CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 859 -106.55 54.47 REMARK 500 ASP A 869 75.18 -117.72 REMARK 500 ASP A 976 38.12 -153.08 REMARK 500 TRP A1106 48.40 -87.55 REMARK 500 ASP B 869 79.72 -117.28 REMARK 500 SER B 919 -78.43 -68.32 REMARK 500 ALA B 920 96.92 -177.38 REMARK 500 ASN B 924 52.86 -116.89 REMARK 500 ASP B 976 38.25 -153.88 REMARK 500 GLU B1015 84.40 49.02 REMARK 500 TRP B1106 49.27 -88.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 50Y A 4000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 50Y B 4000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5CF5 RELATED DB: PDB REMARK 900 RELATED ID: 5CF6 RELATED DB: PDB REMARK 900 RELATED ID: 5CF8 RELATED DB: PDB DBREF 5CF4 A 839 1132 UNP O60674 JAK2_HUMAN 839 1132 DBREF 5CF4 B 839 1132 UNP O60674 JAK2_HUMAN 839 1132 SEQADV 5CF4 MET A 818 UNP O60674 INITIATING METHIONINE SEQADV 5CF4 GLY A 819 UNP O60674 EXPRESSION TAG SEQADV 5CF4 SER A 820 UNP O60674 EXPRESSION TAG SEQADV 5CF4 SER A 821 UNP O60674 EXPRESSION TAG SEQADV 5CF4 HIS A 822 UNP O60674 EXPRESSION TAG SEQADV 5CF4 HIS A 823 UNP O60674 EXPRESSION TAG SEQADV 5CF4 HIS A 824 UNP O60674 EXPRESSION TAG SEQADV 5CF4 HIS A 825 UNP O60674 EXPRESSION TAG SEQADV 5CF4 HIS A 826 UNP O60674 EXPRESSION TAG SEQADV 5CF4 HIS A 827 UNP O60674 EXPRESSION TAG SEQADV 5CF4 SER A 828 UNP O60674 EXPRESSION TAG SEQADV 5CF4 SER A 829 UNP O60674 EXPRESSION TAG SEQADV 5CF4 GLY A 830 UNP O60674 EXPRESSION TAG SEQADV 5CF4 LEU A 831 UNP O60674 EXPRESSION TAG SEQADV 5CF4 VAL A 832 UNP O60674 EXPRESSION TAG SEQADV 5CF4 PRO A 833 UNP O60674 EXPRESSION TAG SEQADV 5CF4 ARG A 834 UNP O60674 EXPRESSION TAG SEQADV 5CF4 GLY A 835 UNP O60674 EXPRESSION TAG SEQADV 5CF4 SER A 836 UNP O60674 EXPRESSION TAG SEQADV 5CF4 HIS A 837 UNP O60674 EXPRESSION TAG SEQADV 5CF4 MET A 838 UNP O60674 EXPRESSION TAG SEQADV 5CF4 HIS A 1133 UNP O60674 EXPRESSION TAG SEQADV 5CF4 HIS A 1134 UNP O60674 EXPRESSION TAG SEQADV 5CF4 HIS A 1135 UNP O60674 EXPRESSION TAG SEQADV 5CF4 HIS A 1136 UNP O60674 EXPRESSION TAG SEQADV 5CF4 HIS A 1137 UNP O60674 EXPRESSION TAG SEQADV 5CF4 HIS A 1138 UNP O60674 EXPRESSION TAG SEQADV 5CF4 MET B 818 UNP O60674 INITIATING METHIONINE SEQADV 5CF4 GLY B 819 UNP O60674 EXPRESSION TAG SEQADV 5CF4 SER B 820 UNP O60674 EXPRESSION TAG SEQADV 5CF4 SER B 821 UNP O60674 EXPRESSION TAG SEQADV 5CF4 HIS B 822 UNP O60674 EXPRESSION TAG SEQADV 5CF4 HIS B 823 UNP O60674 EXPRESSION TAG SEQADV 5CF4 HIS B 824 UNP O60674 EXPRESSION TAG SEQADV 5CF4 HIS B 825 UNP O60674 EXPRESSION TAG SEQADV 5CF4 HIS B 826 UNP O60674 EXPRESSION TAG SEQADV 5CF4 HIS B 827 UNP O60674 EXPRESSION TAG SEQADV 5CF4 SER B 828 UNP O60674 EXPRESSION TAG SEQADV 5CF4 SER B 829 UNP O60674 EXPRESSION TAG SEQADV 5CF4 GLY B 830 UNP O60674 EXPRESSION TAG SEQADV 5CF4 LEU B 831 UNP O60674 EXPRESSION TAG SEQADV 5CF4 VAL B 832 UNP O60674 EXPRESSION TAG SEQADV 5CF4 PRO B 833 UNP O60674 EXPRESSION TAG SEQADV 5CF4 ARG B 834 UNP O60674 EXPRESSION TAG SEQADV 5CF4 GLY B 835 UNP O60674 EXPRESSION TAG SEQADV 5CF4 SER B 836 UNP O60674 EXPRESSION TAG SEQADV 5CF4 HIS B 837 UNP O60674 EXPRESSION TAG SEQADV 5CF4 MET B 838 UNP O60674 EXPRESSION TAG SEQADV 5CF4 HIS B 1133 UNP O60674 EXPRESSION TAG SEQADV 5CF4 HIS B 1134 UNP O60674 EXPRESSION TAG SEQADV 5CF4 HIS B 1135 UNP O60674 EXPRESSION TAG SEQADV 5CF4 HIS B 1136 UNP O60674 EXPRESSION TAG SEQADV 5CF4 HIS B 1137 UNP O60674 EXPRESSION TAG SEQADV 5CF4 HIS B 1138 UNP O60674 EXPRESSION TAG SEQRES 1 A 321 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 321 LEU VAL PRO ARG GLY SER HIS MET ARG ASP PRO THR GLN SEQRES 3 A 321 PHE GLU GLU ARG HIS LEU LYS PHE LEU GLN GLN LEU GLY SEQRES 4 A 321 LYS GLY ASN PHE GLY SER VAL GLU MET CYS ARG TYR ASP SEQRES 5 A 321 PRO LEU GLN ASP ASN THR GLY GLU VAL VAL ALA VAL LYS SEQRES 6 A 321 LYS LEU GLN HIS SER THR GLU GLU HIS LEU ARG ASP PHE SEQRES 7 A 321 GLU ARG GLU ILE GLU ILE LEU LYS SER LEU GLN HIS ASP SEQRES 8 A 321 ASN ILE VAL LYS TYR LYS GLY VAL CYS TYR SER ALA GLY SEQRES 9 A 321 ARG ARG ASN LEU LYS LEU ILE MET GLU TYR LEU PRO TYR SEQRES 10 A 321 GLY SER LEU ARG ASP TYR LEU GLN LYS HIS LYS GLU ARG SEQRES 11 A 321 ILE ASP HIS ILE LYS LEU LEU GLN TYR THR SER GLN ILE SEQRES 12 A 321 CYS LYS GLY MET GLU TYR LEU GLY THR LYS ARG TYR ILE SEQRES 13 A 321 HIS ARG ASP LEU ALA THR ARG ASN ILE LEU VAL GLU ASN SEQRES 14 A 321 GLU ASN ARG VAL LYS ILE GLY ASP PHE GLY LEU THR LYS SEQRES 15 A 321 VAL LEU PRO GLN ASP LYS GLU PTR PTR LYS VAL LYS GLU SEQRES 16 A 321 PRO GLY GLU SER PRO ILE PHE TRP TYR ALA PRO GLU SER SEQRES 17 A 321 LEU THR GLU SER LYS PHE SER VAL ALA SER ASP VAL TRP SEQRES 18 A 321 SER PHE GLY VAL VAL LEU TYR GLU LEU PHE THR TYR ILE SEQRES 19 A 321 GLU LYS SER LYS SER PRO PRO ALA GLU PHE MET ARG MET SEQRES 20 A 321 ILE GLY ASN ASP LYS GLN GLY GLN MET ILE VAL PHE HIS SEQRES 21 A 321 LEU ILE GLU LEU LEU LYS ASN ASN GLY ARG LEU PRO ARG SEQRES 22 A 321 PRO ASP GLY CYS PRO ASP GLU ILE TYR MET ILE MET THR SEQRES 23 A 321 GLU CYS TRP ASN ASN ASN VAL ASN GLN ARG PRO SER PHE SEQRES 24 A 321 ARG ASP LEU ALA LEU ARG VAL ASP GLN ILE ARG ASP ASN SEQRES 25 A 321 MET ALA GLY HIS HIS HIS HIS HIS HIS SEQRES 1 B 321 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 321 LEU VAL PRO ARG GLY SER HIS MET ARG ASP PRO THR GLN SEQRES 3 B 321 PHE GLU GLU ARG HIS LEU LYS PHE LEU GLN GLN LEU GLY SEQRES 4 B 321 LYS GLY ASN PHE GLY SER VAL GLU MET CYS ARG TYR ASP SEQRES 5 B 321 PRO LEU GLN ASP ASN THR GLY GLU VAL VAL ALA VAL LYS SEQRES 6 B 321 LYS LEU GLN HIS SER THR GLU GLU HIS LEU ARG ASP PHE SEQRES 7 B 321 GLU ARG GLU ILE GLU ILE LEU LYS SER LEU GLN HIS ASP SEQRES 8 B 321 ASN ILE VAL LYS TYR LYS GLY VAL CYS TYR SER ALA GLY SEQRES 9 B 321 ARG ARG ASN LEU LYS LEU ILE MET GLU TYR LEU PRO TYR SEQRES 10 B 321 GLY SER LEU ARG ASP TYR LEU GLN LYS HIS LYS GLU ARG SEQRES 11 B 321 ILE ASP HIS ILE LYS LEU LEU GLN TYR THR SER GLN ILE SEQRES 12 B 321 CYS LYS GLY MET GLU TYR LEU GLY THR LYS ARG TYR ILE SEQRES 13 B 321 HIS ARG ASP LEU ALA THR ARG ASN ILE LEU VAL GLU ASN SEQRES 14 B 321 GLU ASN ARG VAL LYS ILE GLY ASP PHE GLY LEU THR LYS SEQRES 15 B 321 VAL LEU PRO GLN ASP LYS GLU PTR PTR LYS VAL LYS GLU SEQRES 16 B 321 PRO GLY GLU SER PRO ILE PHE TRP TYR ALA PRO GLU SER SEQRES 17 B 321 LEU THR GLU SER LYS PHE SER VAL ALA SER ASP VAL TRP SEQRES 18 B 321 SER PHE GLY VAL VAL LEU TYR GLU LEU PHE THR TYR ILE SEQRES 19 B 321 GLU LYS SER LYS SER PRO PRO ALA GLU PHE MET ARG MET SEQRES 20 B 321 ILE GLY ASN ASP LYS GLN GLY GLN MET ILE VAL PHE HIS SEQRES 21 B 321 LEU ILE GLU LEU LEU LYS ASN ASN GLY ARG LEU PRO ARG SEQRES 22 B 321 PRO ASP GLY CYS PRO ASP GLU ILE TYR MET ILE MET THR SEQRES 23 B 321 GLU CYS TRP ASN ASN ASN VAL ASN GLN ARG PRO SER PHE SEQRES 24 B 321 ARG ASP LEU ALA LEU ARG VAL ASP GLN ILE ARG ASP ASN SEQRES 25 B 321 MET ALA GLY HIS HIS HIS HIS HIS HIS MODRES 5CF4 PTR A 1007 TYR MODIFIED RESIDUE MODRES 5CF4 PTR A 1008 TYR MODIFIED RESIDUE MODRES 5CF4 PTR B 1007 TYR MODIFIED RESIDUE MODRES 5CF4 PTR B 1008 TYR MODIFIED RESIDUE HET PTR A1007 16 HET PTR A1008 16 HET PTR B1007 16 HET PTR B1008 16 HET 50Y A4000 30 HET 50Y B4000 30 HETNAM PTR O-PHOSPHOTYROSINE HETNAM 50Y N,N-DICYCLOPROPYL-6-ETHYL-4-[(3-METHOXYPROPYL)AMINO]-1- HETNAM 2 50Y METHYL-1,6-DIHYDROIMIDAZO[4,5-D]PYRROLO[2,3- HETNAM 3 50Y B]PYRIDINE-7-CARBOXAMIDE HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 4(C9 H12 N O6 P) FORMUL 3 50Y 2(C22 H30 N6 O2) FORMUL 5 HOH *249(H2 O) HELIX 1 AA1 GLU A 845 ARG A 847 5 3 HELIX 2 AA2 THR A 888 SER A 904 1 17 HELIX 3 AA3 SER A 936 HIS A 944 1 9 HELIX 4 AA4 ASP A 949 THR A 969 1 21 HELIX 5 AA5 ALA A 978 ARG A 980 5 3 HELIX 6 AA6 PRO A 1017 TYR A 1021 5 5 HELIX 7 AA7 ALA A 1022 SER A 1029 1 8 HELIX 8 AA8 SER A 1032 THR A 1049 1 18 HELIX 9 AA9 GLU A 1052 LYS A 1055 5 4 HELIX 10 AB1 SER A 1056 GLY A 1066 1 11 HELIX 11 AB2 GLN A 1072 ASN A 1084 1 13 HELIX 12 AB3 PRO A 1095 TRP A 1106 1 12 HELIX 13 AB4 ASN A 1109 ARG A 1113 5 5 HELIX 14 AB5 SER A 1115 ALA A 1131 1 17 HELIX 15 AB6 GLU B 845 ARG B 847 5 3 HELIX 16 AB7 THR B 888 SER B 904 1 17 HELIX 17 AB8 SER B 936 LYS B 945 1 10 HELIX 18 AB9 ASP B 949 THR B 969 1 21 HELIX 19 AC1 ALA B 978 ARG B 980 5 3 HELIX 20 AC2 PRO B 1017 TYR B 1021 5 5 HELIX 21 AC3 ALA B 1022 SER B 1029 1 8 HELIX 22 AC4 SER B 1032 TYR B 1050 1 19 HELIX 23 AC5 GLU B 1052 LYS B 1055 5 4 HELIX 24 AC6 SER B 1056 GLY B 1066 1 11 HELIX 25 AC7 GLN B 1072 ASN B 1084 1 13 HELIX 26 AC8 PRO B 1095 TRP B 1106 1 12 HELIX 27 AC9 ASN B 1109 ARG B 1113 5 5 HELIX 28 AD1 SER B 1115 GLY B 1132 1 18 SHEET 1 AA1 5 LEU A 849 GLY A 858 0 SHEET 2 AA1 5 GLY A 861 TYR A 868 -1 O MET A 865 N GLN A 853 SHEET 3 AA1 5 GLU A 877 LEU A 884 -1 O GLU A 877 N TYR A 868 SHEET 4 AA1 5 LYS A 926 GLU A 930 -1 O LEU A 927 N LYS A 882 SHEET 5 AA1 5 TYR A 913 CYS A 917 -1 N LYS A 914 O ILE A 928 SHEET 1 AA2 2 TYR A 972 ILE A 973 0 SHEET 2 AA2 2 LYS A 999 VAL A1000 -1 O LYS A 999 N ILE A 973 SHEET 1 AA3 2 ILE A 982 ASN A 986 0 SHEET 2 AA3 2 ARG A 989 ILE A 992 -1 O LYS A 991 N LEU A 983 SHEET 1 AA4 2 PTR A1008 LYS A1009 0 SHEET 2 AA4 2 LYS A1030 PHE A1031 -1 O PHE A1031 N PTR A1008 SHEET 1 AA5 5 LEU B 849 LYS B 857 0 SHEET 2 AA5 5 GLY B 861 TYR B 868 -1 O MET B 865 N GLN B 853 SHEET 3 AA5 5 GLU B 877 LEU B 884 -1 O VAL B 881 N GLU B 864 SHEET 4 AA5 5 LYS B 926 GLU B 930 -1 O LEU B 927 N LYS B 882 SHEET 5 AA5 5 TYR B 913 CYS B 917 -1 N LYS B 914 O ILE B 928 SHEET 1 AA6 2 TYR B 972 ILE B 973 0 SHEET 2 AA6 2 LYS B 999 VAL B1000 -1 O LYS B 999 N ILE B 973 SHEET 1 AA7 2 ILE B 982 ASN B 986 0 SHEET 2 AA7 2 ARG B 989 ILE B 992 -1 O LYS B 991 N LEU B 983 SHEET 1 AA8 2 PTR B1008 LYS B1009 0 SHEET 2 AA8 2 LYS B1030 PHE B1031 -1 O PHE B1031 N PTR B1008 LINK C GLU A1006 N PTR A1007 1555 1555 1.34 LINK C PTR A1007 N PTR A1008 1555 1555 1.32 LINK C PTR A1008 N LYS A1009 1555 1555 1.36 LINK C GLU B1006 N PTR B1007 1555 1555 1.34 LINK C PTR B1007 N PTR B1008 1555 1555 1.33 LINK C PTR B1008 N LYS B1009 1555 1555 1.32 SITE 1 AC1 18 LEU A 855 GLY A 856 GLY A 858 VAL A 863 SITE 2 AC1 18 ALA A 880 GLU A 930 TYR A 931 LEU A 932 SITE 3 AC1 18 PRO A 933 GLY A 935 SER A 936 ARG A 980 SITE 4 AC1 18 LEU A 983 GLY A 993 ASP A 994 HOH A4152 SITE 5 AC1 18 ARG B 947 GLU B 987 SITE 1 AC2 13 LEU B 855 GLY B 856 VAL B 863 ALA B 880 SITE 2 AC2 13 GLU B 930 TYR B 931 LEU B 932 PRO B 933 SITE 3 AC2 13 GLY B 935 ARG B 980 ASN B 981 LEU B 983 SITE 4 AC2 13 ASP B 994 CRYST1 112.460 112.460 70.500 90.00 90.00 90.00 P 41 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008892 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008892 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014184 0.00000